ArticlePharmaceuticals (Basel, Switzerland)2023

Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes-Interventional Study.

Marcin Hachuła et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.